Skip to Content
Merck
  • A novel cationic liposome reagent for efficient transfection of mammalian cells.

A novel cationic liposome reagent for efficient transfection of mammalian cells.

Biochemical and biophysical research communications (1991-08-30)
X Gao, L Huang
ABSTRACT

A novel cationic derivative of cholesterol, 3 beta [N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol), has been synthesized and used to prepare sonicated liposomes with dioleoylphosphatidylethanolamine. This novel cationic liposome reagent facilitates efficient DNA mediated transfection in A431 human epidermoid carcinoma cells, A549 human lung carcinoma cells, L929 mouse fibroblast cells, and YPT minipig primary endothelial cells. The activity was greater than that of a commercial reagent, Lipofectin, and was approximately 4-fold less toxic than Lipofectin when assayed with A431 cells. The reagent is easy to synthesize and stable for at least 6 weeks.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cholesteryl 3β-N-(di­methyl­amino­ethyl)­carbamate hydrochloride, ≥95%
Sigma-Aldrich
L-α-Phosphatidylethanolamine, dioleoyl, ≥99% (GC), ≥98% (TLC), lyophilized powder
Sigma-Aldrich
Cholesteryl N-(2-dimethylaminoethyl)carbamate, ≥98% (TLC)